Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rang in aandelen #27020
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aandeelprijs
$0.16240909
Laatst gesynchroniseerd: 2025-03-04
Marktkapitalisatie
$35.68M
Verandering (1 dag)
0.27%
Verandering (1 jaar)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Categorie

Dividendgeschiedenis van Dali Pharmaceuticalco.,Ltd (603963)
Dali Pharmaceuticalco.,Ltd (aandelsymbool: 603963) heeft in totaal 3 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $0.15
Dividendrendement (TTM): 0
Dividendbetalingen voor Dali Pharmaceuticalco.,Ltd (603963) van 2018 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
2026 (TTM) $0.046 0.00%
2021 $0.046 -22.30%
2019 $0.0592 30.11%
2018 $0.0455 0.00%
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
2026 (TTM) $0.046 0.00%
2021 $0.046 -54.05%
2019 $0.1001 0.10%
2018 $0.1 0.00%
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten